The Intracellular Cholesterol Landscape: Dynamic Integrator of the Immune Response

Trends in Immunology

Volumn 37, Issue 12, 2016, Pages 819-830

  Fessler, Michael B ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYCHOLESTEROL; CHOLESTEROL; INFLAMMASOME; INTERFERON; LIVER X RECEPTOR; MEVALONIC ACID; OXYSTEROL; STEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN; T LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN RECEPTOR;

ADAPTIVE IMMUNITY; ALLOSTERISM; CELLULAR IMMUNITY; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR SPACE; LIPID METABOLISM; LIPID TRANSPORT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE; MOLECULAR DYNAMICS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; STEROL METABOLISM; T LYMPHOCYTE; TH17 CELL; ANIMAL; HOMEOSTASIS; IMMUNITY; IMMUNOLOGY; METABOLISM;

ANIMALS; CHOLESTEROL; HOMEOSTASIS; HUMANS; IMMUNITY; INTERFERONS; INTRACELLULAR SPACE; MACROPHAGES; MEVALONIC ACID; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84999066580     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2016.09.001     Document Type: Review

References (76)

1. 1 Howe, V., et al. Cholesterol homeostasis: how do cells sense sterol excess?. Chem. Phys. Lipids 199 (2016), 170–178.
2. 2 Lange, Y., Steck, T.L., Active membrane cholesterol as a physiological effector. Chem. Phys. Lipids 199 (2016), 74–93.
3. 3 Kulig, W., et al. Cholesterol oxidation products and their biological importance. Chem. Phys. Lipids 199 (2016), 144–160.
4. 4 Radhakrishnan, A., et al. Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab. 8 (2008), 512–521.
5. 5 York, A.G., et al. Limiting cholesterol biosynthetic flux spontaneously engages Type I IFN signaling. Cell 163 (2015), 1716–1729.
6. 6 Molnar, E., et al. Cholesterol and sphingomyelin drive ligand-independent T-cell antigen receptor nanoclustering. J. Biol. Chem. 287 (2012), 42664–42674.
7. 7 Reboldi, A., et al. Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. Science 345 (2014), 679–684.
8. 8 Tall, A.R., Yvan-Charvet, L., Cholesterol, inflammation and innate immunity. Nat. Rev. Immunol. 15 (2015), 104–116.
9. 9 Raccosta, L., et al. The oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils. J. Exp. Med. 210 (2013), 1711–1728.
10. 10 Cyster, J.G., et al. 25-Hydroxycholesterols in innate and adaptive immunity. Nat. Rev. Immunol. 14 (2014), 731–743.
11. 11 Kiyotake, R., et al. Human mincle binds to cholesterol crystals and triggers innate immune responses. J. Biol. Chem. 290 (2015), 25322–25332.
12. 12 Hu, X., et al. Sterol metabolism controls T(H)17 differentiation by generating endogenous RORgamma agonists. Nat. Chem. Biol. 11 (2015), 141–147.
13. 13 Bensinger, S.J., et al. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 134 (2008), 97–111.
14. 14 Kidani, Y., et al. Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity. Nat. Immunol. 14 (2013), 489–499.
15. 15 Akula, M.K., et al. Control of the innate immune response by the mevalonate pathway. Nat. Immunol. 17 (2016), 922–929.
16. 16 Joseph, S.B., et al. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9 (2003), 213–219.
17. 17 Ghisletti, S., et al. Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. Mol. Cell 25 (2007), 57–70.
18. 18 Lee, J.H., et al. Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes. Mol. Cell 35 (2009), 806–817.
19. 19 Ito, A., et al. LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling. Elife, 4, 2015, e08009.
20. −/−mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 279–284.
21. 21 Pourcet, B., et al. LXRalpha regulates macrophage arginase 1 through PU.1 and interferon regulatory factor 8. Circ. Res. 109 (2011), 492–501.
22. 22 Villablanca, E.J., et al. Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses. Nat. Med. 16 (2010), 98–105.
23. 23 Feig, J.E., et al. LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. J. Clin. Invest. 120 (2010), 4415–4424.
24. 24 Li, P., et al. NCoR repression of LXRs restricts macrophage biosynthesis of insulin-sensitizing omega 3 fatty acids. Cell 155 (2013), 200–214.
25. 25 Rong, X., et al. LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition. Cell Metab. 18 (2013), 685–697.
26. 26 Ishibashi, M., et al. Liver X receptor regulates arachidonic acid distribution and eicosanoid release in human macrophages: a key role for lysophosphatidylcholine acyltransferase 3. Arterioscler. Thromb. Vasc. Biol. 33 (2013), 1171–1179.
27. 27 A-Gonzalez, N., et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31 (2009), 245–258.
28. 28 Casanova-Acebes, M., et al. Rhythmic modulation of the hematopoietic niche through neutrophil clearance. Cell 153 (2013), 1025–1035.
29. 29 A-Gonzalez, N., et al. The nuclear receptor LXRalpha controls the functional specialization of splenic macrophages. Nat. Immunol. 14 (2013), 831–839.
30. 30 Spann, N.J., et al. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 151 (2012), 138–152.
31. 31 Bauman, D.R., et al. 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production. Proc. Natl. Acad. Sci. U.S.A. 106 (2009), 16764–16769.
32. 32 Gold, E.S., et al. 25-Hydroxycholesterol acts as an amplifier of inflammatory signaling. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 10666–10671.
33. 33 Hannedouche, S., et al. Oxysterols direct immune cell migration via EBI2. Nature 475 (2011), 524–527.
34. 34 Liu, C., et al. Oxysterols direct B-cell migration through EBI2. Nature 475 (2011), 519–523.
35. 35 Yi, T., Cyster, J.G., EBI2-mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen capture. Elife, 2, 2013, e00757.
36. 36 Xiao, H., et al. Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility. Circulation 128 (2013), 632–642.
37. 37 McRae, S., et al. The hepatitis C virus-induced NLRP3 inflammasome activates the sterol regulatory element-binding protein (SREBP) and regulates lipid metabolism. J. Biol. Chem. 291 (2016), 3254–3267.
38. 38 Samstad, E.O., et al. Cholesterol crystals induce complement-dependent inflammasome activation and cytokine release. J. Immunol. 192 (2014), 2837–2845.
39. 39 Warnatsch, A., et al. Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis. Science 349 (2015), 316–320.
40. 40 Progatzky, F., et al. Dietary cholesterol directly induces acute inflammasome-dependent intestinal inflammation. Nat. Commun., 5, 2014, 5864.
41. 41 Chukkapalli, V., et al. Lipids at the interface of virus-host interactions. Curr. Opin. Microbiol. 15 (2012), 512–518.
42. 42 Coppens, I., Targeting lipid biosynthesis and salvage in apicomplexan parasites for improved chemotherapies. Nat. Rev. Microbiol. 11 (2013), 823–835.
43. 43 Wipperman, M.F., et al. Pathogen roid rage: cholesterol utilization by Mycobacterium tuberculosis. Crit. Rev. Biochem. Mol. Biol. 49 (2014), 269–293.
44. 44 Syed, G.H., et al. Hepatitis C virus hijacks host lipid metabolism. Trends Endocrinol. Metab. 21 (2010), 33–40.
45. 45 Kleinfelter, L.M., et al. Haploid genetic screen reveals a profound and direct dependence on cholesterol for hantavirus membrane fusion. MBio, 6, 2015, e00801.
46. 46 Petersen, J., et al. The major cellular sterol regulatory pathway is required for Andes virus infection. PLoS Pathog., 10, 2014, e1003911.
47. 47 Cui, H.L., et al. HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux. J. Lipid Res. 53 (2012), 696–708.
48. 48 Ilnytska, O., et al. Enteroviruses harness the cellular endocytic machinery to remodel the host cell cholesterol landscape for effective viral replication. Cell Host Microbe 14 (2013), 281–293.
49. 49 Blanc, M., et al. Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. PLoS Biol., 9, 2011, e1000598.
50. 50 Robertson, K.A., et al. An interferon regulated microRNA provides broad cell-intrinsic antiviral immunity through multihit host-directed targeting of the sterol pathway. PLoS Biol., 14, 2016, e1002364.
51. 51 Amini-Bavil-Olyaee, S., et al. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 13 (2013), 452–464.
52. 52 Wang, X., et al. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2 (2007), 96–105.
53. 53 Singaravelu, R., et al. MicroRNAs regulate the immunometabolic response to viral infection in the liver. Nat. Chem. Biol. 11 (2015), 988–993.
54. 54 Owens, C.M., et al. Chemical combinations elucidate pathway interactions and regulation relevant to hepatitis C replication. Mol. Syst. Biol., 6, 2010, 375.
55. 55 Morrow, M.P., et al. Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1. Mol. Pharmacol. 78 (2010), 215–225.
56. 56 Bocchetta, S., et al. Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection. PLoS One, 9, 2014, e92140.
57. 57 Civra, A., et al. Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol. Sci. Rep., 4, 2014, 7487.
58. 58 Liu, S.Y., et al. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. Immunity 38 (2013), 92–105.
59. 59 Roulin, P.S., et al. Rhinovirus uses a phosphatidylinositol 4-phosphate/cholesterol counter-current for the formation of replication compartments at the ER-Golgi interface. Cell Host Microbe 16 (2014), 677–690.
60. 60 Anggakusuma, et al. Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation. Hepatology 62 (2015), 702–714.
61. 61 Chen, Y., et al. Interferon-inducible cholesterol-25-hydroxylase inhibits hepatitis C virus replication via distinct mechanisms. Sci. Rep., 4, 2014, 7242.
62. 62 Shibata, N., et al. 25-Hydroxycholesterol activates the integrated stress response to reprogram transcription and translation in macrophages. J. Biol. Chem. 288 (2013), 35812–35823.
63. reg-cell function. Nature 499 (2013), 485–490.
64. 64 Thurnher, M., Gruenbacher, G., T lymphocyte regulation by mevalonate metabolism. Sci. Signal., 8, 2015, re4.
65. 65 Fessler, M.B., Parks, J.S., Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J. Immunol. 187 (2011), 1529–1535.
66. 66 Armstrong, A.J., et al. ATP-binding cassette transporter G1 negatively regulates thymocyte and peripheral lymphocyte proliferation. J. Immunol. 184 (2010), 173–183.
67. 67 Cheng, H.Y., et al. Increased cholesterol content in gammadelta (gammadelta) T lymphocytes differentially regulates their activation. PLoS One, 8, 2013, e63746.
68. + T cells by modulating cholesterol metabolism. Nature 531 (2016), 651–655.
69. 69 Wang, F., et al. Inhibition of T cell receptor signaling by cholesterol sulfate, a naturally occurring derivative of membrane cholesterol. Nat. Immunol. 17 (2016), 844–850.
70. 70 Swamy, M., et al. A cholesterol-based allostery model of T cell receptor phosphorylation. Immunity 44 (2016), 1091–1101.
71. 71 Soroosh, P., et al. Oxysterols are agonist ligands of RORgammat and drive Th17 cell differentiation. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 12163–12168.
72. 72 Santori, F.R., et al. Identification of natural RORgamma ligands that regulate the development of lymphoid cells. Cell Metab. 21 (2015), 286–297.
73. 73 Cui, G., et al. Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J. Clin. Invest. 121 (2011), 658–670.
74. 74 Jeon, T.I., Osborne, T.F., SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol. Metab. 23 (2012), 65–72.
75. 75 Spann, N.J., Glass, C.K., Sterols and oxysterols in immune cell function. Nat. Immunol. 14 (2013), 893–900.
76. 76 Blanc, M., et al. The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. Immunity 38 (2013), 106–118.